CXCL8 and triple-negative breast carcinoma: There was one study found that eugenol could enhance the inhibition of cisplatin on NF-κB signaling pathway and IL-8 secretion, thereby effectively reducing the proportion of ALDH1A1high stem cells, reducing drug resistance, and increasing drug sensitivity in triple-negative breast cancer.19